Contact
searchSearch
HMP Global

Advertisement

Advertisement

ADVERTISEMENT

September 2014 - FRMC

Department
Specialty Pharmacy Trends Report: Rheumatoid Arthritis
09/22/2014
Rheumatoid arthritis (RA) is a chronic inflammatory disorder that primarily affects small joints in the hands and feet.
Rheumatoid arthritis (RA) is a chronic inflammatory disorder that primarily affects small joints in the hands and feet.
Rheumatoid arthritis (RA) is a...
09/22/2014
First Report Managed Care
Department
Specialty Pharmacy Trends Report: Psoriasis/Psoriatic Arthritis
09/22/2014
Psoriasis is an autoimmune disease in which excessive skin cell growth results in thick, discolored patches of skin. Some individuals with psoriasis may also develop psoriatic arthritis (PsA), in which the immune system attacks the joints,...
Psoriasis is an autoimmune disease in which excessive skin cell growth results in thick, discolored patches of skin. Some individuals with psoriasis may also develop psoriatic arthritis (PsA), in which the immune system attacks the joints,...
Psoriasis is an autoimmune...
09/22/2014
First Report Managed Care
Department
Specialty Pharmacy Trends Report: Oncology
09/22/2014
According to the CDC, globally, about 14 million people each year are diagnosed with cancer, while 8 million people die from the disease.
According to the CDC, globally, about 14 million people each year are diagnosed with cancer, while 8 million people die from the disease.
According to the CDC, globally,...
09/22/2014
First Report Managed Care
Data Show Improved HbA1c with Canagliflozin
09/22/2014

Eileen Koutnik-Fotopoulos

Eileen Koutnik-Fotopoulos
San Francisco—Clinical trials of canagliflozin improved hemoglobin A1c (HbA1c) in patients with type 2 diabetes compared with sitagliptin, according to data from 2 studies presented at the ADA meeting during a product theater sponsored by...
San Francisco—Clinical trials of canagliflozin improved hemoglobin A1c (HbA1c) in patients with type 2 diabetes compared with sitagliptin, according to data from 2 studies presented at the ADA meeting during a product theater sponsored by...
San Francisco—Clinical trials of...
09/22/2014
First Report Managed Care
Research Expanding into Diabetic Kidney Disease
09/22/2014

Eileen Koutnik-Fotopoulos

Eileen Koutnik-Fotopoulos
San Francisco—Diabetic kidney disease is 1 of the more common long-term complications of diabetes.
San Francisco—Diabetic kidney disease is 1 of the more common long-term complications of diabetes.
San Francisco—Diabetic kidney...
09/22/2014
First Report Managed Care
Managing Charcot Foot
09/22/2014

Eileen Koutnik-Fotopoulos

Eileen Koutnik-Fotopoulos
Charcot foot is a significant complication that individuals with diabetes develop in relation to peripheral neuropathy of the foot.
Charcot foot is a significant complication that individuals with diabetes develop in relation to peripheral neuropathy of the foot.
Charcot foot is a significant...
09/22/2014
First Report Managed Care
Changing Patient Behavior Can Lead to Effective Coping
09/22/2014

Eileen Koutnik-Fotopoulos

Eileen Koutnik-Fotopoulos
San Francisco—Diabetes care requires a truly collaborative approach where patients and clinicians relate as equals, according to David G. Marrero, PhD, JO Ritchey Society, professor of medicine, Indiana University School of Medicine. Dr....
San Francisco—Diabetes care requires a truly collaborative approach where patients and clinicians relate as equals, according to David G. Marrero, PhD, JO Ritchey Society, professor of medicine, Indiana University School of Medicine. Dr....
San Francisco—Diabetes care...
09/22/2014
First Report Managed Care
Newly-Approved Empagliflozin for Obese Patients with Type 2 Diabetes
09/22/2014

Tim Casey

Tim Casey
San Francisco—After 52 weeks of treatment, obese patients with type 2 diabetes who received empagliflozin as an add-on therapy to daily insulin injections had improved glucose control, experienced weight loss, and had no increase in...
San Francisco—After 52 weeks of treatment, obese patients with type 2 diabetes who received empagliflozin as an add-on therapy to daily insulin injections had improved glucose control, experienced weight loss, and had no increase in...
San Francisco—After 52 weeks of...
09/22/2014
First Report Managed Care
Emerging Therapies in Diabetic Retinopathy
09/22/2014

Eileen Koutnik-Fotopoulos

Eileen Koutnik-Fotopoulos
San Francisco—Diabetic retinopathy, a term used for all abnormalities of the small blood vessels of the retina caused by diabetes, is estimated to be the most frequent cause of new cases of blindness among adults 20 to 74 years of age. All...
San Francisco—Diabetic retinopathy, a term used for all abnormalities of the small blood vessels of the retina caused by diabetes, is estimated to be the most frequent cause of new cases of blindness among adults 20 to 74 years of age. All...
San Francisco—Diabetic...
09/22/2014
First Report Managed Care
Experts Discuss Diabetic Dyslipidemia
09/22/2014

Eileen Koutnik-Fotopoulos

Eileen Koutnik-Fotopoulos
San Francisco—Diabetic dyslipidemia is a well-recognized factor for atherosclerotic cardiovascular disease. Characteristic dyslipidemia of insulin resistance and type 2 diabetes presents with a triad of lipid abnormalities, including...
San Francisco—Diabetic dyslipidemia is a well-recognized factor for atherosclerotic cardiovascular disease. Characteristic dyslipidemia of insulin resistance and type 2 diabetes presents with a triad of lipid abnormalities, including...
San Francisco—Diabetic...
09/22/2014
First Report Managed Care

Advertisement

Advertisement

Advertisement

FRMC Volume 21, Issue 2

Current Issue

June 2024
Volume 21
Issue 2
Current Issue
Issue Archive

Advertisement

Advertisement

What's Trending?

News
Drug Makers to Justify Costs, Disclose Price Hikes under Proposed California Law
06/28/2016
A recently proposed California law that would require drug makers to justify the costs of their treatments and disclose any major price hikes has invoked strong opposition from the pharmaceutical industry. 
A recently proposed California law that would require drug makers to justify the costs of their treatments and disclose any major price hikes has invoked strong opposition from the pharmaceutical industry. 
A recently proposed California...
06/28/2016
First Report Managed Care
News
Audits Reveal Millions in Medicare Advantage Overcharges
11/21/2022

Fred Schulte and Holly Hacker

Fred Schulte and Holly Hacker, Kaiser...
Newly released federal audits showed Medicare Advantage plans overbilled the government by approximately $12 million.
Newly released federal audits showed Medicare Advantage plans overbilled the government by approximately $12 million.
Newly released federal audits...
11/21/2022
First Report Managed Care
Prostate Cancer Treatments Pose Challenges for Managed Care
11/29/2011

Tim Casey

Tim Casey
Atlanta—With the introduction of several new therapies, the treatment for castration-resistant prostate cancer (CRPC) has gone through a dramatic shift in recent years. By the end of the decade, the market for prostate cancer is expected to...
Atlanta—With the introduction of several new therapies, the treatment for castration-resistant prostate cancer (CRPC) has gone through a dramatic shift in recent years. By the end of the decade, the market for prostate cancer is expected to...
Atlanta—With the introduction of...
11/29/2011
First Report Managed Care
News
As Medicaid Budgets Squeezed, States Consider Eccentric Ideas On Cutting Costs
03/30/2011
03/30/2011
First Report Managed Care
News
Progress Made on How Medicare Pays Doctors
05/10/2012
05/10/2012
First Report Managed Care

Video Insights

Hayward
Videos
Evolving Health Care Contact Centers Into Drivers of Value-Based Care
07/31/2024
Discover how health care contact centers can transform into drivers of value-based care through AI, automation, upskilling agents, and rethinking workflows and metrics to improve patient outcomes and population health.
Discover how health care contact centers can transform into drivers of value-based care through AI, automation, upskilling agents, and rethinking workflows and metrics to improve patient outcomes and population health.
Discover how health care contact...
07/31/2024
First Report Managed Care
Lucille Accetta Headshot
Videos
Enhancing Patient Medication Adherence: Insights and Strategies From Asembia 2024
06/11/2024
Lucille Accetta, PharmD, MBA, MSPH, Senior Vice President of CVS Specialty Operations
Key stakeholders in the health care industry gathered to discuss prevalent topics at this year's Asembia annual summit. Medication adherence emerged as one of the most talked-about issues. In a session led by Lucille Accetta, PharmD, MBA,...
Key stakeholders in the health care industry gathered to discuss prevalent topics at this year's Asembia annual summit. Medication adherence emerged as one of the most talked-about issues. In a session led by Lucille Accetta, PharmD, MBA,...
Key stakeholders in the health...
06/11/2024
First Report Managed Care
Melissa Andel, Principal, CommonHealth Solutions, LLC
Videos
Navigating the Impact of the Inflation Reduction Act: Implications for Payers, Patients, and Manufacturers
05/24/2024
Melissa Andel, Principal, CommonHealth Solutions, LLC
Learn about the impacts of the Inflation Reduction Act on payers and patients, highlighting the changes in Medicare benefits and drug coverage coming in 2025 and 2026.
Learn about the impacts of the Inflation Reduction Act on payers and patients, highlighting the changes in Medicare benefits and drug coverage coming in 2025 and 2026.
Learn about the impacts of the...
05/24/2024
First Report Managed Care
Joe DePinto Headshot
Videos
Navigating Payment Models in the CGT Landscape: Insights and Innovations
05/21/2024
Joe DePinto, Head of Cell, Gene, and Advanced Therapies, McKesson
An expert discusses the evolution and challenges of payment models in the cell and gene therapy (CGT) space reviewed during his session at Asembia 2024.
An expert discusses the evolution and challenges of payment models in the cell and gene therapy (CGT) space reviewed during his session at Asembia 2024.
An expert discusses the...
05/21/2024
First Report Managed Care
Jennifer L. Mathieu Senior Vice President, Professional and Government Affairs at AMCP
Videos
Unlocking the Future of Managed Care Pharmacy: A Deep Dive into Federal Legislation and Regulations
05/15/2024
Jennifer L. Mathieu Senior Vice President, Professional and Government Affairs, AMCP
Learn about developments in federal legislation and regulations within the pharmacy landscape shaping the future of managed care in an interview with a session presenter from AMCP 2024.
Learn about developments in federal legislation and regulations within the pharmacy landscape shaping the future of managed care in an interview with a session presenter from AMCP 2024.
Learn about developments in...
05/15/2024
First Report Managed Care
Tejaswi Kompala
Videos
Personalizing Weight Loss Management With GLP-1 Agonists
04/05/2024

Featuring Tejaswi Kompala, MD, head of cardiometabolic clinical strategy, Teladoc 

Featuring Tejaswi Kompala, MD, head o...
Delve into the rising demand for anti-obesity medications, the complexities of obesity management, and the importance of personalized approaches in improving cardiometabolic health in this insightful interview.
Delve into the rising demand for anti-obesity medications, the complexities of obesity management, and the importance of personalized approaches in improving cardiometabolic health in this insightful interview.
Delve into the rising demand for...
04/05/2024
First Report Managed Care
Zaubler Headshot
Videos
Integrating Behavioral Health Services to Reduce ED Visits: Substance Use Disorder and Social Determinants of Health
03/27/2024

Featuring Tom Zaubler, MD, MPH, CMO at NeuroFlow

Featuring Tom Zaubler, MD, MPH, CMO a...
Join us for the continuation of an engaging two-part series showcasing an expert dedicated to reducing emergency department visits through the integration of behavioral health practices. Dr Zaubler will share invaluable insights into...
Join us for the continuation of an engaging two-part series showcasing an expert dedicated to reducing emergency department visits through the integration of behavioral health practices. Dr Zaubler will share invaluable insights into...
Join us for the continuation of...
03/27/2024
First Report Managed Care
Zaubler Headshot
Videos
Integrating Behavioral Health Services to Reduce ED Visits: Suicide Prevention and Preemptive Primary Care
03/25/2024

Featuring Tom Zaubler, MD, MPH, CMO at NeuroFlow

Featuring Tom Zaubler, MD, MPH, CMO a...
Come join us for the first installment of a captivating two-part series featuring an expert committed to minimizing emergency department visits through the implementation of behavioral health integrations. Dr Zaubler will offer valuable...
Come join us for the first installment of a captivating two-part series featuring an expert committed to minimizing emergency department visits through the implementation of behavioral health integrations. Dr Zaubler will offer valuable...
Come join us for the first...
03/25/2024
First Report Managed Care
Yash Prajapati
Videos
Navigating the Evolution of Digital Solutions in Health Care
02/27/2024

Featuring Yash Prajapati, consultant at ZS Associates 

Featuring Yash Prajapati, consultant ...
Join us in exploring the challenges and opportunities in the development, approval, and integration of digital therapeutic solutions with ZS Associates consultant Yash Prajapati.
Join us in exploring the challenges and opportunities in the development, approval, and integration of digital therapeutic solutions with ZS Associates consultant Yash Prajapati.
Join us in exploring the...
02/27/2024
First Report Managed Care
Mansur Shomali
Videos
Advancements and Challenges in Diabetes Management
02/27/2024

Featuring Mansur Shomali, MD, chief medical officer at Welldoc, endocrinologist at MedStar Health 

Featuring Mansur Shomali, MD, chief m...
Learn about the state of digital therapeutics for disease management such as diabetes care in terms of cost, outcomes, integration, and more with Dr Mansur Shomali, CMO at Welldoc.
Learn about the state of digital therapeutics for disease management such as diabetes care in terms of cost, outcomes, integration, and more with Dr Mansur Shomali, CMO at Welldoc.
Learn about the state of digital...
02/27/2024
First Report Managed Care

Subscribe to our eNewsletters!

First Report Managed Care Newsletter

September 2014 Volume 11 Issue 9

View Issue Archive
Editorial Correspondence

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use

Advertisement

Advertisement